Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-04

Clinical Trial Update: Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating immediate radiation with GammaTile at glioblastoma excision versus standard of care; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GammaTile

Snippet

Sponsor: GT Medical Technologies, Inc. | Conditions: Glioblastoma | Phase 3 | Status: RECRUITING